Arcturus Therapeutics Holdings

$40.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.81 (+2.05%) Today

+$0.17 (+0.42%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ARCT and other stocks, options, and ETFs commission-free!

About ARCT

Arcturus Therapeutics Holdings Inc. Common Stock, also called Arcturus Therapeutics Holdings, is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases.

CEO

Joseph E. Payne

Employees

118

Headquarters

San Diego, California

Founded

2013

Market Cap

1.06B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

616.47K

High Today

$40.41

Low Today

$38.53

Open Price

$39.75

Volume

515.35K

52 Week High

$129.71

52 Week Low

$17.00

Analyst Ratings

50%

of 12 ratings

Buy

50%

Hold

33%

Sell

17%

ARCT Earnings

-$1.25

-$0.83

-$0.42

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours